Call 0800 923 2079 any day, any time

Infographic: Meningitis, 10 key statistics

  • 0 comments

    Today the government made a U-turn on an earlier decision and have now agreed to introduce the Meningitis B vaccine into their childhood vaccination programme.

    By Kerstin Kubiak

The charity Meningitis Now were thrilled to confirm today that the government has announced all children will now be routinely offered the Meningitis B vaccine as part of standard NHS care, subject to an agreement with the supplying drug company on pricing.

Meningitis Now and many parents who have lost children or whose children were badly affected by the disease have campaigned tirelessly for this decision. It is a really fantastic achievement for all those involved.

In a press release the charity stated: “The ground-breaking vaccine stands to save thousands of lives and many from life-changing after effects such as limb loss, brain damage and epilepsy.”

It’s hoped by all that the negotiations to agree the pricing of the vaccine and to implement the programme will be swift.

Find the charity and further information on Twitter : @MeningitisNow #meningitis

Our Experience

I and my colleagues act for a number of clients, both children and adults, who have suffered injury due to issues with treatment for meningitis.  The issue is usually a delayed response to symptoms of meningitis causing delayed diagnosis and crucially delayed treatment.  Where a young child is affected the impact can be catastrophic as the child can suffer injury to their brain which has lifelong effects, leaving the child requiring care and assistance.

Timing is crucial with meningitis and prompt diagnosis and treatment can make a difference to the outcome for the child.  It is hoped that with this vaccine being more widely available then more children will be protected against this condition.

The Clinical Negligence Team have prepared a the following Infographic on some key facts and statistics relating to meningitis:

meningitis_infographic

Want to know more?

Share this

Leave a Comment

Your email address will not be published. Required fields are marked *

Explore our site